NIKKEI 225
38,482.11 +379.67 (+1.00%) HANG SENG
17,915.55 -20.57 (-0.11%) CRUDE OIL
81.55 -0.02 (-0.02%) GOLD FUTURES
2,344.20 -2.70 (-0.12%) DOW
38,834.86 +56.76 (+0.15%) Bitcoin GBP
51,274.85 -1,159.42 (-2.21%)
BioMarin Pharmaceutical Inc. (BM8.F)
| Previous close | 77.80 |
| Open | 79.00 |
| Bid | 78.64 x 2300 |
| Ask | 78.68 x 2200 |
| Day's range | 79.00 - 79.00 |
| 52-week range | 68.26 - 90.52 |
| Volume | |
| Avg. volume | 9 |
| Market cap | 15.318B |
| Beta (5Y monthly) | 0.31 |
| PE ratio (TTM) | 79.80 |
| EPS (TTM) | 0.99 |
| Earnings date | 29 Jul 2024 - 02 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 110.83 |
ZacksMirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
Mirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PR NewswireBioMarin to Present Data Highlighting Significant Impact of VOXZOGO® (vosoritide) in Bone Health and Health-Related Quality of Life in Achondroplasia at 2024 International Conference on Children's Bone Health
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced the presentation of new data from an investigator-led analysis of the Phase 2 111-205 study, which demonstrate that children with achondroplasia treated with VOXZOGO® experienced increases in bone length while maintaining bone strength. The data will be presented at the 11th International Conference on Children's Bone Health (ICCBH) in Salzburg, Austria, June 22-25, 2024. BioMarin will also share the first results from a study underscor
PR NewswireKKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap
